Sunar Ulas, Rohrbach Daniel J, Morgan Janet, Zeitouni Natalie, Henderson Barbara W
Department of Cell Stress Biology & PDT Center, Roswell Park Cancer Institute, Buffalo, NY 14263, USA.
Biomed Opt Express. 2013 Apr 1;4(4):531-7. doi: 10.1364/BOE.4.000531. Epub 2013 Mar 6.
5-aminolaevulinic acid photodynamic therapy (ALA-PDT) is an attractive treatment option for nonmelanoma skin tumors, especially for multiple lesions and large areas. The efficacy of ALA-PDT is highly dependent on the photosensitizer (PS) concentration present in the tumor. Thus it is desirable to quantify PS concentration and distribution, preferably noninvasively to determine potential outcome. Here we quantified protoporphyrin IX (PpIX) distribution induced by topical and intra-tumoral (it) administration of the prodrug ALA in basal and squamous cell carcinoma murine models by using spatial frequency domain imaging (SFDI). The in vivo measurements were validated by analysis of the ex vivo extraction of PpIX. The study demonstrates the feasibility of non-invasive quantification of PpIX distributions in skin tumors.
5-氨基酮戊酸光动力疗法(ALA-PDT)是治疗非黑素瘤皮肤肿瘤的一种有吸引力的选择,特别是对于多发性病变和大面积病变。ALA-PDT的疗效高度依赖于肿瘤中存在的光敏剂(PS)浓度。因此,希望对PS浓度和分布进行量化,最好是通过非侵入性方法来确定潜在的治疗效果。在此,我们通过空间频域成像(SFDI)对前体药物ALA经局部和瘤内给药后在基底细胞癌和鳞状细胞癌小鼠模型中诱导产生的原卟啉IX(PpIX)分布进行了量化。通过对PpIX的离体提取物进行分析,验证了体内测量结果。该研究证明了对皮肤肿瘤中PpIX分布进行非侵入性量化的可行性。